ADAM and ADAMTS proteases as integrative hubs in heart failure pathogenesis and therapy.

Authors

Xinyu Wang, Yujie He, Yuyan Wang, Yue Liu, Xinyu Dai, Yunhao Xia, Lanzhi Du, Chang Li, Dan Zhang

Published in

iScience. Volume 29. Issue 7. Pages 116533. Jul 17, 2026. Epub Jun 26, 2026.

Abstract

Heart failure (HF) arises from multifactorial disruptions in cellular signaling, inflammation, and tissue remodeling beyond classical neurohormonal regulation. Increasing evidence highlights ADAM and ADAMTS metalloproteinases as central integrators of inflammatory, fibrotic, and hypertrophic pathways. This review establishes a dual integrative framework. Horizontally, distinct protease family members converge within each pathological axis, including inflammation, fibrosis, hypertrophy and remodeling, metabolism, and angiogenesis, to drive disease progression. Vertically, individual proteases, such as ADAM17, coordinate multiple axes through various effectors that activate distinct downstream pathways, exhibiting both detrimental and protective functions. These mechanistic insights guide the development of selective inhibitors to circumvent pitfalls associated with broad-spectrum MMP targeting. Additionally, emerging ADAM and ADAMTS family members show promise as diagnostic and prognostic biomarkers in cardiovascular diseases (CVDs). By synthesizing mechanistic depth with translational relevance, this framework reveals protease-centered opportunities for precision intervention and outlines essential future research directions.

PMID:
42491712
Bibliographic data and abstract were imported from PubMed on 24 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.